B Eidinger & Son Drug Corp entered the industry of in 1980 and has grown to employ 1 to 4 people, generating an annual revenue of $1.000.000 to $2.499.999. The NAICS classifies this business under the code 446110, which describes it as a . For further clarification, the SIC classifies this business under the code 5912 and described it as a . The business provides service to the B2C market.
To acquire more information, please contact Mitchell Barell by calling (719) 989-8958 during business hours. You can also write to the business’ Single Location at 250 3rd Avenue Front, New York City, New York NY 10010. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | B Eidinger & Son Drug Corp |
| Representative: | Mitchell Barell |
| Place of Business: | 250 3rd Avenue Front, New York City, NY 10010 |
| Contact Number: | (719) 989-8958 |
| Type of Service: | |
| SIC Number: | 5912 |
| NAICS Number: | 446110 |
| Locality: | Single Location |
| Market Type: | B2C (Business to Consumer) |
| Began: | 1980 |
| Income/Year: | $1.000.000 to $2.499.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
B Eidinger & Son Drug Corp is a company operating from New York, New York providing professional and relevant B2C variables. It was founded in 1980 and registered with the SIC code 5912 as , and with the NAICS code 446110 as .
With a current employee count of 1 to 4, B Eidinger & Son Drug Corp has gone to report making $1.000.000 to $2.499.999 per annum on its journey towards growth. This company invites you to contact its representative Mitchell Barell at (719) 989-8958 for related queries, or to locate its Single Location using the coordinates .
The Single Location can also be found at the street address 250 3rd Avenue Front in New York City, New York 10010 and can be engaged online through the company website at , the company Twitter , and Facebook page .